Clinical Trials Directory

Trials / Sponsors / Bridge Biotherapeutics, Inc.

Bridge Biotherapeutics, Inc.

Industry · 10 registered clinical trials.

StatusTrialPhaseStarted
Active Not RecruitingFirst-in-Human Study of BBT-207 in Advanced Non-Small Cell Lung Cancer Harboring EGFR Mutation After Treatment
EGFR Mutant Advanced Non-Small Cell Lung Cancer
Phase 1 / Phase 22023-09-11
CompletedTo Evaluate the Efficacy, Safety, and Tolerability of BBT-877 in Patients With IPF
Idiopathic Pulmonary Fibrosis
Phase 22023-04-12
CompletedEfficacy and Safety of Orally Administered BBT-401-1S in Subjects With Ulcerative Colitis
Ulcerative Colitis
Phase 22021-06-11
TerminatedEfficacy and Safety of Rectally Administered BBT-401-1S in Subjects With Ulcerative Colitis
Ulcerative Colitis
Phase 12021-06-01
TerminatedPhase 1/2 Study of BBT-176 in Advanced NSCLC With Progression After EGFR TKI Treatment
NSCLC
Phase 1 / Phase 22021-04-02
CompletedEvaluate Safety, Pharmacokinetics and Pharmacodynamics of BBT-877 in Healthy Japanese Male
Healthy Participants
Phase 12019-10-01
CompletedAssess the Drug Interactions of BBT-877 and Midazolam, Itraconazole, and Esomeprazole in Healthy Adult Subject
Healthy Participants
Phase 12019-09-17
TerminatedEfficacy and Safety of BBT-401-1S in Ulcerative Colitis
Ulcerative Colitis
Phase 22019-04-22
CompletedSafety, Tolerability, Pharmacokinetics, and Pharmacodynamics of BBT-877 in Healthy Subjects
Idiopathic Pulmonary Fibrosis
Phase 12019-02-13
CompletedFirst-In-Human Study of BBT-401-1S Following Single and Multiple Ascending Doses in Healthy Volunteers
Ulcerative Colitis
Phase 12018-03-20